Lucid Diagnostics Releases Positive Data from First Prospect

Multicenter observational study documents excellent concordance of EsoGuard results with subsequent medical decision-making by multiple physicians
NEW YORK, Sept. 7, 2023 /PRNewswire/ -- Lucid...

Related Keywords

Lishan Aklog , Nasdaq , Pavmed Inc , Exchange Commission , Lucid Diagnostics Inc , Lucid Diagnostics , Clinical Utility Study , Samples Collected , Triage Test , Identify Barrett , Interim Data , Senior Vice President , Chief Medical Officer , Cell Collection Device , Chief Executive , Esophageal Cell Collection Device , Annual Report , Quarterly Report , Markets ,